Avid Bioservices Statistics
Share Statistics
Avid Bioservices has 63.96M shares outstanding. The number of shares has increased by 0.88% in one year.
| Shares Outstanding | 63.96M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0.5% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 63.22M |
| Failed to Deliver (FTD) Shares | 62.48K |
| FTD / Avg. Volume | 3.33% |
Short Selling Information
The latest short interest is 13.51M, so 21.12% of the outstanding shares have been sold short.
| Short Interest | 13.51M |
| Short % of Shares Out | 21.12% |
| Short % of Float | 21.37% |
| Short Ratio (days to cover) | 24.11 |
Valuation Ratios
The PE ratio is -3.43 and the forward PE ratio is -174.71.
| PE Ratio | -3.43 |
| Forward PE | -174.71 |
| PS Ratio | 3.45 |
| Forward PS | 4.8 |
| PB Ratio | 7.92 |
| P/FCF Ratio | -23.12 |
| PEG Ratio | n/a |
Enterprise Valuation
Avid Bioservices Inc. has an Enterprise Value (EV) of 1.26B.
| EV / Earnings | -8.93 |
| EV / Sales | 8.98 |
| EV / EBITDA | -109.45 |
| EV / EBIT | -67.28 |
| EV / FCF | -60.26 |
Financial Position
The company has a current ratio of 1.47, with a Debt / Equity ratio of 2.55.
| Current Ratio | 1.47 |
| Quick Ratio | 1.04 |
| Debt / Equity | 2.55 |
| Total Debt / Capitalization | 71.8 |
| Cash Flow / Debt | 0.07 |
| Interest Coverage | -4.31 |
Financial Efficiency
Return on equity (ROE) is -2.31% and return on capital (ROIC) is -36.33%.
| Return on Equity (ROE) | -2.31% |
| Return on Assets (ROA) | -0.42% |
| Return on Capital (ROIC) | -36.33% |
| Revenue Per Employee | 377.12K |
| Profits Per Employee | -379.39K |
| Employee Count | 371 |
| Asset Turnover | 0.42 |
| Inventory Turnover | 4.37 |
Taxes
| Income Tax | 113.83M |
| Effective Tax Rate | -4.23 |
Stock Price Statistics
The stock price has increased by 101.63% in the last 52 weeks. The beta is 1.41, so Avid Bioservices 's price volatility has been higher than the market average.
| Beta | 1.41 |
| 52-Week Price Change | 101.63% |
| 50-Day Moving Average | 11.27 |
| 200-Day Moving Average | 9.28 |
| Relative Strength Index (RSI) | 65.69 |
| Average Volume (20 Days) | 1.88M |
Income Statement
In the last 12 months, Avid Bioservices had revenue of $139.91M and earned -$140.75M in profits. Earnings per share was $-2.23.
| Revenue | 139.91M |
| Gross Profit | 7.32M |
| Operating Income | -18.68M |
| Net Income | -140.75M |
| EBITDA | -11.48M |
| EBIT | -18.68M |
| Earnings Per Share (EPS) | -2.23 |
Balance Sheet
The company has $38.11M in cash and $207.83M in debt, giving a net cash position of -$169.73M.
| Cash & Cash Equivalents | 38.11M |
| Total Debt | 207.83M |
| Net Cash | -169.73M |
| Retained Earnings | -571.87M |
| Total Assets | 323.48M |
| Working Capital | 22.35M |
Cash Flow
In the last 12 months, operating cash flow was $10.95M and capital expenditures -$31.80M, giving a free cash flow of -$20.85M.
| Operating Cash Flow | 10.95M |
| Capital Expenditures | -31.80M |
| Free Cash Flow | -20.85M |
| FCF Per Share | -0.33 |
Margins
Gross margin is 5.23%, with operating and profit margins of -13.35% and -100.6%.
| Gross Margin | 5.23% |
| Operating Margin | -13.35% |
| Pretax Margin | -19.25% |
| Profit Margin | -100.6% |
| EBITDA Margin | -8.21% |
| EBIT Margin | -13.35% |
| FCF Margin | -14.9% |
Dividends & Yields
CDMO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -18.07% |
| FCF Yield | -2.64% |
Analyst Forecast
The average price target for CDMO is $12.25, which is -0.7% lower than the current price. The consensus rating is "Hold".
| Price Target | $12.25 |
| Price Target Difference | -0.7% |
| Analyst Consensus | Hold |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Jul 10, 2017. It was a backward split with a ratio of 1:7.
| Last Split Date | Jul 10, 2017 |
| Split Type | backward |
| Split Ratio | 1:7 |
Scores
| Altman Z-Score | -0.6 |
| Piotroski F-Score | 3 |